𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Long-term safety of long-acting risperidone microspheres

✍ Scribed by M. Eerdekens; W.W. Fleischhacker; X. Yang; L. Beauclair; H. Sauret; W. Chrzanowski; S. Martin; O. Gefvert

Book ID
119568254
Publisher
Elsevier Science
Year
2002
Tongue
French
Weight
147 KB
Volume
17
Category
Article
ISSN
0924-9338

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Long-term safety and efficacy of long-ac
Long-term safety and efficacy of long-acting risperidone in elderly psychotic patients
✍ Werner Kissling; Per Glue; Rossella Medori; Steve Simpson πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 144 KB πŸ‘ 1 views

## Abstract This subgroup analysis of the 6‐month, open‐label Switch to Risperidone Microspheres (StoRMi) trial evaluated long‐term safety and efficacy of a direct conversion to risperidone long‐acting injectable (RLAI) in 52 elderly patients (β‰₯65 years) with psychosis stabilized on oral or depot a

Initial experience with long-acting risp
Initial experience with long-acting risperidone microspheres injection
✍ Nicholas Keks; Cyril Been; Russell D’Souza; Rajan Thomas; Philip Tune; Jenny Ba πŸ“‚ Article πŸ“… 2003 πŸ› Informa plc 🌐 English βš– 82 KB

Objective: To report initial clinical experience with the injectable long-acting microspheres formulation of the atypical antipsychotic risperidone. Methods: Case reports. Results: The seven patients described have had good outcomes to date. A patient who has received the drug for 2 years has

Risperidone long-acting injection
Risperidone long-acting injection
✍ Chue, Pierre πŸ“‚ Article πŸ“… 2003 πŸ› Expert Reviews 🌐 English βš– 215 KB